Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2006 2
2009 3
2010 1
2013 1
2015 2
2018 1
2019 1
2020 2
2021 1
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Antivascular actions of microtubule-binding drugs.
Schwartz EL. Schwartz EL. Clin Cancer Res. 2009 Apr 15;15(8):2594-601. doi: 10.1158/1078-0432.CCR-08-2710. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351751 Free PMC article. Review.
Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma.
Wang J, Ferrena A, Zhang R, Singh S, Viscarret V, Al-Harden W, Aldahamsheh O, Borjihan H, Singla A, Yaguare S, Tingling J, Zi X, Lo Y, Gorlick R, Schwartz EL, Zhao H, Yang R, Geller DS, Zheng D, Hoang BH. Wang J, et al. Among authors: schwartz el. Oncogene. 2024 Mar;43(13):962-975. doi: 10.1038/s41388-024-02942-4. Epub 2024 Feb 14. Oncogene. 2024. PMID: 38355807 Free PMC article.
SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis.
Ferrena A, Wang J, Zhang R, Karadal-Ferrena B, Al-Hardan W, Singh S, Borjihan H, Schwartz EL, Zhao H, Oktay MH, Yang R, Geller DS, Hoang BH, Zheng D. Ferrena A, et al. Among authors: schwartz el. Mol Cancer Ther. 2024 Feb 1;23(2):223-234. doi: 10.1158/1535-7163.MCT-23-0173. Mol Cancer Ther. 2024. PMID: 37871911
The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma.
Wang J, Aldahamsheh O, Ferrena A, Borjihan H, Singla A, Yaguare S, Singh S, Viscarret V, Tingling J, Zi X, Lo Y, Gorlick R, Zheng D, Schwartz EL, Zhao H, Yang R, Geller DS, Hoang BH. Wang J, et al. Among authors: schwartz el. Ann N Y Acad Sci. 2021 Apr;1490(1):90-104. doi: 10.1111/nyas.14578. Epub 2021 Feb 16. Ann N Y Acad Sci. 2021. PMID: 33594717 Free PMC article.
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcoma.
Wang J, Sato K, O'Donnell E, Singla A, Yaguare S, Aldahamsheh O, Batko B, Borjihan H, Tingling J, Zhang J, Weiser DA, Loeb DM, Gorlick R, Schwartz EL, Yang R, Zi X, Zhao H, Geller DS, Hoang BH. Wang J, et al. Among authors: schwartz el. Transl Oncol. 2020 Oct;13(10):100809. doi: 10.1016/j.tranon.2020.100809. Epub 2020 Jul 2. Transl Oncol. 2020. PMID: 32623326 Free PMC article.
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.
Cheng H, Zou Y, Ross JS, Wang K, Liu X, Halmos B, Ali SM, Liu H, Verma A, Montagna C, Chachoua A, Goel S, Schwartz EL, Zhu C, Shan J, Yu Y, Gritsman K, Yelensky R, Lipson D, Otto G, Hawryluk M, Stephens PJ, Miller VA, Piperdi B, Perez-Soler R. Cheng H, et al. Among authors: schwartz el. Cancer Discov. 2015 Dec;5(12):1262-70. doi: 10.1158/2159-8290.CD-14-0971. Epub 2015 Sep 14. Cancer Discov. 2015. PMID: 26370156 Free PMC article.
22 results